Arkolith/Insider Trading/NLTX/Form 4

Drachman Jonathan G

President and CEO, DirectorNeoleukin Therapeutics, Inc. (NLTX) · full profile →Form 4 · filed Aug 26, 2021
Net Buying
Open-Market Buys
$934K
Open-Market Sells
$0
Net Open-Market Flow
$934K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 25, 2021Buy(P)25K$6.45$161K25K
Aug 25, 2021Buy(P)25K$6.45$161K25K
Aug 24, 2021Buy(P)100K$6.11$611K2.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-053544) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML